Appendix A
Workshop Agenda

Assessing and Improving Value in Cancer Care

A National Cancer Policy Forum Workshop


Monday and Tuesday, February 9 and 10, 2009

NAS Lecture Room

National Academy of Sciences Building

2100 C Street, NW

Washington, DC


DAY ONE

8:00 a.m.

Welcome, Introductory Remarks: What Is Value in Cancer Care? Why Is It Important?

Scott D. Ramsey, Fred Hutchinson Cancer Research Center

8:20

Physician–Patient Communication and Its Influence on Value

 

Moderator: Allen S. Lichter, American Society of Clinical Oncology

8:25

Inside the Physician–Patient Discussion in Cancer Care

Speaker: Anthony Back, University of Washington

8:55

Invited Comments from Diane Blum, CancerCare

9:00

Can We Communicate Effectively with Cancer Patients About the Benefits and Risks of Cancer Treatments?

Speaker: Peter A. Ubel, University of Michigan



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 125
Appendix A Workshop Agenda Assessing and Improving Value in Cancer Care A National Cancer Policy Forum Workshop Monday and Tuesday, February 9 and 10, 2009 NAS Lecture Room National Academy of Sciences Building 2100 C Street, NW Washington, DC DAy ONE 8:00 a.m. Welcome, Introductory Remarks: What Is Value in Cancer Care? Why Is It Important? Scott D. Ramsey, fred Hutchinson Cancer Research Center 8:20 Physician–Patient Communication and Its Influence on Value Moderator: Allen S. Lichter, American Society of Clinical Oncology 8:25 Inside the Physician–Patient Discussion in Cancer Care Speaker: Anthony Back, university of Washington 8:55 Invited Comments from Diane Blum, CancerCare 9:00 Can We Communicate Effectively with Cancer Patients About the Benefits and Risks of Cancer Treatments? Speaker: Peter A. Ubel, university of michigan 

OCR for page 125
 ASSESSINg ANd ImPROVINg VAluE IN CANCER CARE 9:30 Invited Comments from Mary McCabe, memorial Sloan-kettering Cancer Survivorship Program 9:35 Therapy for Advanced-Stage Cancer: What Do Patients Want and Expect? Speaker: Robert Erwin, marti Nelson Cancer foundation 10:05 Invited Comments from Ellen Stovall, National Coalition for Cancer Survivorship 10:10 Discussion 10:40 10-Minute Break 10:50 Generating Evidence About Effectiveness and Value Moderator: Steven B. Cohen, Agency for Healthcare Research and Quality 10:55 FDA Perspectives on Evidence for Regulatory Approval in Cancer Speaker: Janet Woodcock, food and drug Administration 11:25 What Constitutes Reasonable Evidence of Efficacy and Effectiveness? Speaker: Daniel J. Sargent, mayo Clinic 11:55 Discussion 12:25 p.m. Lunch 1:00 Value and the Oncology Market Moderator: Jeffrey C. Lerner, ECRI Institute 1:05 Drug Pricing and Value in Oncology vs. Other Areas in Medicine Speaker: Patricia M. Danzon, university of Pennsylvania 1:35 Industry Perspective on Pharmaceutical Pricing in Oncology Speaker: Greg Rossi, genentech, Inc.

OCR for page 125
7 APPENdIx A 2:05 Cost Implications: Strategies to Enhance Value in Oncology Speaker: Deborah Schrag, dana-farber/Harvard Cancer Center 2:35 Discussion 3:20 10-Minute Break 3:30 Value in Cancer Practice: Health Insurer Perspectives Moderator: Scott D. Ramsey, fred Hutchinson Cancer Research Center 3:35 Oncologists’ Perception of Value in Oncology Speaker: Peter J. Neumann, Tufts medical Center 4:05 Paying for New Cancer Treatments: Rights and Responsibilities of Health Insurers Speaker: Lee Newcomer, united Healthcare 4:35 European Experience and Perspectives on Evaluating Value for Oncology Products Speaker: Michael Drummond, Centre for Health Economics, university of York 5:05 Discussion 5:50 Adjourned for the day DAy TWO 8:00 a.m. Ethical Issues for Value-Based Decision Making in Oncology Moderator: Harold L. Moses, Vanderbilt-Ingram Cancer Center 8:05 Ethical Issues When Considering Insurance Coverage Based on Value in the Treatment of Cancer Speaker: Dan W. Brock, Harvard medical School

OCR for page 125
8 ASSESSINg ANd ImPROVINg VAluE IN CANCER CARE 8:35 Patient–Physician Communication on Therapy Options for Cancer: Ethical Issues Speaker: Neil S. Wenger, university of California, los Angeles 9:05 Discussion 9:35 10-Minute Break 9:45 Improving Value in Oncology Practice: Ways Forward Moderator: Lou Garrison, university of Washington 9:50 Value-Based Insurance Design—Initiatives Outside of Oncology Speaker: Michael Chernew, Harvard medical School 10:20 Generating Evidence of Value Post-FDA Approval: Is There a Role for Health Insurers? Speaker: Sean R. Tunis, Center for medical Technology Policy 10:50 Are There Ways to Improve the Value of Cancer Care That May Work at the Bedside? Speaker: Thomas J. Smith, Virginia Commonwealth university 11:20 Discussion WORkING LUNCH 12:05 p.m. Toward a Shared Understanding of Value: Can We Agree, and Does Perspective Matter? Moderator: Peter Bach, memorial Sloan-kettering Cancer Center Panel: All Moderators 1:30 Meeting Adjourned